Introduction Intrahepatic cholangiocarcinoma (ICC) incidence continues to rise worldwide,
and overall survival remains poor. Complete surgical resection remains the only opportunity …

Intrahepatic cholangiocarcinoma (ICC) is a rare, aggressive cancer of the biliary tract. It often
presents with locally advanced or metastatic disease, but for patients with early-stage …

These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were
commissioned by the British Society of Gastroenterology liver section. The guideline writing …

Purpose To report outcomes of yttrium-90 (90 Y) radioembolization in patients with
unresectable intrahepatic cholangiocarcinoma (ICC). Materials and Methods Retrospective …

Background: This paper offers an assessment of radiomics tools in the evaluation of
intrahepatic cholangiocarcinoma. Methods: The PubMed database was searched for papers …

Background: Cholangiocarcinoma (CCA) is a relatively rare malignant biliary system tumor,
and yet it represents the second most common primary hepatic neoplasm, following …

Results Forty-one patients were included. Thirty-one were positive for malignancy and 10
were negative. Fifteen were metastatic. Of 31, 18 were CC and 6 were HCC. For overall …

To this date, it is a major oncological challenge to optimally diagnose, stage, and manage
intrahepatic cholangiocarcinoma (ICC). Imaging can not only diagnose and stage ICC, but it …

Primary cancers of the liver and biliary tract are rare and aggressive tumors that often
present with locally advanced or metastatic disease. For patients with localized disease …

Purpose Unresectable intrahepatic cholangiocarcinoma (ICC) signifies a poor prognosis
with limited treatment options beyond systemic chemotherapy. This study's purpose was to …